News about cell analysis instruments and tools including flow cytometry, cell counters, high content screening, etc.
Sphere Fluidics Awarded a New Trademark for Cyto-Surf, a novel carrier fluid for Cyto-Mine, in Japan. by Sphere Fluidics | Nov 1, 2017 | News Read more
October 2017 Eppendorf India announces the extension of the training centre at its facility in Ambattur. Eppendorf India, a wholly owned subsidiary of Eppendorf AG, today announces the extension of the training centre at its facility in Ambattur, Chennai. Eppendorf is committed to skill development and this measure further enhances the possibility of offering tailor... Read more
ALAMEDA, Calif.–(BUSINESS WIRE)–Oct. 17, 2017– BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced the closing of its previously announced public offering of 9,615,385 shares of common stock, including 1,442,308 shares sold pursuant to the underwriters’ exercise in full of their... Read more
ALAMEDA, Calif.–(BUSINESS WIRE)–Oct. 13, 2017– BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced the pricing of an underwritten public offering of 9,615,385 shares of its common stock at a public offering price of $2.60 per share. The gross proceeds to BioTime from this offering... Read more
ALAMEDA, Calif.–(BUSINESS WIRE)–Oct. 12, 2017– BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced its intent to offer to sell shares of its common stock in an underwritten public offering. BioTime intends to grant the underwriters a 30-day option to purchase up to... Read more
ALAMEDA, Calif.–(BUSINESS WIRE)–Oct. 12, 2017– BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced its intent to offer to sell shares of its common stock in an underwritten public offering. BioTime intends to grant the underwriters a 30-day option to purchase up to... Read more
Gyros Protein Technologies becomes distributor of iLite® cell-based reporter gene assays for drug development Uppsala and Malmö, Sweden, 11 October 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has signed a distribution agreement withEuro Diagnostica, the full service assay solution company.... Read more
October 10, 2017 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, launched Hunky today, the one and only complete solution for quantifying biologic stability and predicting aggregation. Hunky measures ΔG, the amount of energy it takes to unfold a protein, letting scientists quantify... Read more
October 09, 2017 08:00 AM Pacific Daylight Time ASHLAND, Ore.–(BUSINESS WIRE)–FlowJo, LLC, a bioinformatics and data analysis company with 20 years of experience serving scientists with software for analyzing single-cell data has been awarded the Manufacturing Business of the Year by the Ashland Chamber of Commerce. The award was given in recognition of their commitment... Read more
Positions focus on driving business growth MANASSAS, Va., Oct. 3, 2017 /PRNewswire-USNewswire/ — ATCC, a global leader in biological materials management and standards, today announced two appointments to the senior leadership team. Mr. Daniel Kelly joins ATCC as Chief Information and Technology Officer (CITO), and Mr. John Sweeney joins as Chief Financial Officer (CFO). As CITO, Mr. Kelly will develop and drive... Read more